Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse Model
Background: Kawasaki disease is treated by immunoglobulin therapy, which has adverse side effects like renal damage. Aims: The aim of the present study was to explore the effectiveness of triptolide, a compound derived from threewingnut that has anti-inflammatory effects, on the treatment of Kawa...
Main Authors: | Zong-Ting Yan, Jian-Wen Zou |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2013-06-01
|
Series: | Balkan Medical Journal |
Subjects: | |
Online Access: | http://balkanmedicaljournal.org/text.php?lang=en&id=399 |
Similar Items
-
A new perspective of triptolide-associated hepatotoxicity: the relevance of NF-κB and NF-κB-mediated cellular FLICE-inhibitory protein
by: Ziqiao Yuan, et al.
Published: (2020-05-01) -
Downregulation of miR-200a Protects Mouse Leydig Cells Against Triptolide by Triggering Autophagy
by: Miao H, et al.
Published: (2020-11-01) -
Dissecting The Role Of TNFα In Kawasaki Disease: Alteration Of Cell Fate By TNFα After Superantigen Activation
by: Wong, Aaron
Published: (2011) -
Dissecting The Role Of TNFα In Kawasaki Disease: Alteration Of Cell Fate By TNFα After Superantigen Activation
by: Wong, Aaron
Published: (2011) -
Triptolide-Mediated Apoptotic Cell Death Accelerated by Metformin Co-Treatment in MiaPaca-2 Cells
by: Zeynep Elif Apaydin, et al.
Published: (2019-12-01)